In addition, short-term treatment of Ks Leprdb/db mice with two structurally distinct proteasome inhibitors, epoxomicin and celastrol, significantly reduced hyperglycemia by concomitantly increasing insulin sensitivity and increasing insulin production. Here, INS is linked to Hyperglycemia.